Busky M. Joseph's most recent trade in QuidelOrtho Corporation was a trade of 4,925 Common Stock done . Disclosure was reported to the exchange on March 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2026 | 4,925 | 46,337 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2026 | 4,925 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.78 per share. | 28 Mar 2026 | 1,519 | 44,818 (0%) | 0% | 14.8 | 22,451 | Common Stock |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2026 | 5,968 | 5,969 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2026 | 5,968 | 43,218 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.10 per share. | 08 Feb 2026 | 1,806 | 41,412 (0%) | 0% | 29.1 | 52,555 | Common Stock |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 29,444 | 29,444 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2026 | 8,425 | 16,851 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 8,425 | 39,852 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.41 per share. | 29 Jan 2026 | 2,602 | 37,250 (0%) | 0% | 27.4 | 71,321 | Common Stock |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 26.06 per share. | 24 Nov 2025 | 4,770 | 6,920 (0%) | 0% | 26.1 | 124,305 | Common Stock |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 21,367 | 41,310 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 21,367 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.82 per share. | 30 Jun 2025 | 9,883 | 31,427 (0%) | 0% | 28.8 | 284,828 | Common Stock |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 5,392 | 22,409 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 5,392 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.67 per share. | 01 Jun 2025 | 2,466 | 19,943 (0%) | 0% | 30.7 | 75,632 | Common Stock |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 4,925 | 4,925 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2025 | 4,925 | 18,619 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.89 per share. | 28 Mar 2025 | 1,602 | 17,017 (0%) | 0% | 34.9 | 55,894 | Common Stock |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 5,968 | 11,937 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2025 | 5,968 | 15,752 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.89 per share. | 08 Feb 2025 | 2,058 | 13,694 (0%) | 0% | 42.9 | 88,268 | Common Stock |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 25,276 | 25,276 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 5,391 | 5,392 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 5,391 | 12,230 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.19 per share. | 01 Jun 2024 | 2,446 | 9,784 (0%) | 0% | 44.2 | 108,089 | Common Stock |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 4,925 | 9,073 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2024 | 4,925 | 9,850 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.94 per share. | 28 Mar 2024 | 2,234 | 6,839 (0%) | 0% | 47.9 | 107,098 | Common Stock |
| QuidelOrtho Corporation | M. Busky Joseph | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 21,367 | 21,367 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | M. Busky Joseph | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 46.35 per share. | 23 Feb 2024 | 2,150 | 2,150 (0%) | 0% | 46.4 | 99,663 | Common Stock |
| QuidelOrtho Corporation | Busky M. Joseph | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 17,905 | 17,905 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,391 | 5,583 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 5,391 | 21,565 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.65 per share. | 01 Jun 2023 | 1,637 | 3,946 (0%) | 0% | 85.6 | 140,209 | Common Stock |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2023 | 14,775 | 14,775 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2023 | 14,775 | 14,775 | - | - | Non-Qualified Stock Option | |
| QuidelOrtho Corporation | Joseph M. Busky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 21,012 | 21,012 | - | - | Non-Qualified Stock Option |